| Sanford Mark Meyers, MD | |
|
2454 E Dempster St, 400, Des Plaines, IL 60016-5315 | |
| (847) 299-0700 | |
| (847) 390-0616 |
| Full Name | Sanford Mark Meyers |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 53 Years |
| Location | 2454 E Dempster St, Des Plaines, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659356186 | NPI | - | NPPES |
| 036095435 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 036095435 (Illinois) | Secondary |
| 207WX0107X | Ophthalmology - Retina Specialist | 036095435 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina Consultants, Ltd | 4486633922 | 11 |
News Archive
The Wall Street Journal reports that proposals for cuts in health spending by President Barack Obama's deficit-reduction commission are drawing opposition from health companies, doctors and some consumer groups. "How to tackle health costs has become a sticking point for the 18-member committee, which last week concluded three days of meetings without a firm agreement among members.
A significant milestone has been reached in the development of a new therapy for patients suffering from coronary artery disease. On July 27, 2010 the BIOTRONIK DREAMS (Drug Eluting Absorbable Metal Scaffold) was successfully implanted in the first patient by Prof. Dr. Michael Haude at the Lukaskrankenhaus in Neuss, Germany as part of the first-in-man clinical study BIOSOLVE-I.
Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.
Researchers have provided the first evidence that mass drug administration can grant community-level protection against Plasmodium falciparum (P. falciparum) malaria.
› Verified 7 days ago
| Entity Name | Retina Consultants, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013085992 PECOS PAC ID: 4486633922 Enrollment ID: O20040717000110 |
News Archive
The Wall Street Journal reports that proposals for cuts in health spending by President Barack Obama's deficit-reduction commission are drawing opposition from health companies, doctors and some consumer groups. "How to tackle health costs has become a sticking point for the 18-member committee, which last week concluded three days of meetings without a firm agreement among members.
A significant milestone has been reached in the development of a new therapy for patients suffering from coronary artery disease. On July 27, 2010 the BIOTRONIK DREAMS (Drug Eluting Absorbable Metal Scaffold) was successfully implanted in the first patient by Prof. Dr. Michael Haude at the Lukaskrankenhaus in Neuss, Germany as part of the first-in-man clinical study BIOSOLVE-I.
Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.
Researchers have provided the first evidence that mass drug administration can grant community-level protection against Plasmodium falciparum (P. falciparum) malaria.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sanford Mark Meyers, MD 2454 E Dempster St, 400, Des Plaines, IL 60016-5315 Ph: (847) 299-0700 | Sanford Mark Meyers, MD 2454 E Dempster St, 400, Des Plaines, IL 60016-5315 Ph: (847) 299-0700 |
News Archive
The Wall Street Journal reports that proposals for cuts in health spending by President Barack Obama's deficit-reduction commission are drawing opposition from health companies, doctors and some consumer groups. "How to tackle health costs has become a sticking point for the 18-member committee, which last week concluded three days of meetings without a firm agreement among members.
A significant milestone has been reached in the development of a new therapy for patients suffering from coronary artery disease. On July 27, 2010 the BIOTRONIK DREAMS (Drug Eluting Absorbable Metal Scaffold) was successfully implanted in the first patient by Prof. Dr. Michael Haude at the Lukaskrankenhaus in Neuss, Germany as part of the first-in-man clinical study BIOSOLVE-I.
Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.
Researchers have provided the first evidence that mass drug administration can grant community-level protection against Plasmodium falciparum (P. falciparum) malaria.
› Verified 7 days ago
Dr. Marshall Hirshman, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8901 Golf Rd Ste 300, Suite 300, Des Plaines, IL 60016 Phone: 847-824-3127 Fax: 847-824-3346 | |
Dr. Robert Garoon, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9301 Golf Rd, Des Plaines, IL 60016 Phone: 847-294-0080 | |
Dr. Daniel C Alter, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8901 W. Golf Rd, 206, Des Plaines, IL 60016 Phone: 847-699-0006 Fax: 847-699-1744 | |
Kathryn Winkler, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 940 Lee St, Des Plaines, IL 60016 Phone: 847-299-5501 | |
Dr. Stephen Winkler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 940 Lee St, Des Plaines, IL 60016 Phone: 847-299-5501 Fax: 410-601-6279 | |
Michael J. Shapiro, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2454 E Dempster St, Suite 400, Des Plaines, IL 60016 Phone: 847-299-0700 Fax: 847-390-0616 | |
Stephen A. Vile, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 940 Lee St, Des Plaines, IL 60016 Phone: 847-299-5501 |